Suppressor factors: potential for immunotherapy.
D000361:Agammaglobulinemia / Q000276:immunology; D000906:Antibodies / Q000276:immunology; D000917:Antibody Formation; D001327:Autoimmune Diseases / Q000209:etiology; D001402:B-Lymphocytes / Q000276:immunology; D003208:Concanavalin A / Q000276:immunology; D004247:DNA / Q000096:biosynthesis; D000939:Epitopes / Q000276:immunology; D005802:Genes, MHC Class II; D006131:Growth Inhibitors / Q000276:immunology; D006822:Hybrid Cells / Q000276:immunology; D006967:Hypersensitivity / Q000209:etiology; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000096:biosynthesis; D007167:Immunotherapy; D007372:Interferons / Q000276:immunology; D007959:Lymphocyte Culture Test, Mixed; D009101:Multiple Myeloma / Q000276:immunology; D009712:Nucleotides, Cyclic / Q000276:immunology; D011453:Prostaglandins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism*; D009626:Terminology as Topic; D013951:Thymus Hormones / Q000276:immunology; D000509:alpha-Fetoproteins / Q000276:immunology
D000906:Antibodies; D000939:Epitopes; D006131:Growth Inhibitors; D007136:Immunoglobulins; D009712:Nucleotides, Cyclic; D011453:Prostaglandins; D013951:Thymus Hormones; D000509:alpha-Fetoproteins; D003208:Concanavalin A; D004247:DNA; D007372:Interferons